Literature DB >> 28688130

The pharmaceutical industry needs more clinical pharmacologists.

Richard Peck1.   

Abstract

Mesh:

Year:  2017        PMID: 28688130      PMCID: PMC5651311          DOI: 10.1111/bcp.13370

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  15 in total

1.  Clinical application of pharmacogenetics.

Authors:  B B Spear; M Heath-Chiozzi; J Huff
Journal:  Trends Mol Med       Date:  2001-05       Impact factor: 11.951

Review 2.  How to improve R&D productivity: the pharmaceutical industry's grand challenge.

Authors:  Steven M Paul; Daniel S Mytelka; Christopher T Dunwiddie; Charles C Persinger; Bernard H Munos; Stacy R Lindborg; Aaron L Schacht
Journal:  Nat Rev Drug Discov       Date:  2010-02-19       Impact factor: 84.694

Review 3.  Clinical pharmacology = disease progression + drug action.

Authors:  Nick Holford
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

4.  Personalized medicine: Time for one-person trials.

Authors:  Nicholas J Schork
Journal:  Nature       Date:  2015-04-30       Impact factor: 49.962

Review 5.  Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.

Authors:  H M Jones; Y Chen; C Gibson; T Heimbach; N Parrott; S A Peters; J Snoeys; V V Upreti; M Zheng; S D Hall
Journal:  Clin Pharmacol Ther       Date:  2015-01-09       Impact factor: 6.875

6.  Phase II and phase III failures: 2013-2015.

Authors:  Richard K Harrison
Journal:  Nat Rev Drug Discov       Date:  2016-11-04       Impact factor: 84.694

7.  Pharmacogenetics: The right drug for you.

Authors:  Liam Drew
Journal:  Nature       Date:  2016-09-08       Impact factor: 49.962

8.  Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.

Authors:  Joop van Gerven; Milton Bonelli
Journal:  Br J Clin Pharmacol       Date:  2018-05-30       Impact factor: 4.335

9.  The right dose for every patient: a key step for precision medicine.

Authors:  Richard W Peck
Journal:  Nat Rev Drug Discov       Date:  2015-12-16       Impact factor: 84.694

10.  Mepolizumab treatment in patients with severe eosinophilic asthma.

Authors:  Hector G Ortega; Mark C Liu; Ian D Pavord; Guy G Brusselle; J Mark FitzGerald; Alfredo Chetta; Marc Humbert; Lynn E Katz; Oliver N Keene; Steven W Yancey; Pascal Chanez
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.